Neutrophils as Sources of Extracellular Nucleotides: Functional Consequences at the Vascular Interface

Trends in Cardiovascular Medicine

Volumn 18, Issue 3, 2008, Pages 103-107

  Eltzschig, Holger K ^a,b   MacManus, Christopher F ^a   Colgan, Sean P ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE TRIPHOSPHATE; CONNEXIN 43; NUCLEOTIDE; VASCULAR CELL ADHESION MOLECULE 1;

ENDOTHELIUM CELL; HUMAN; HYPOXIA; INFLAMMATION; MOLECULAR MECHANICS; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN METABOLISM; REVIEW;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL HYPOXIA; ENDOTHELIUM, VASCULAR; HUMANS; NEUTROPHIL ACTIVATION; NEUTROPHILS; NUCLEOTIDES; SIGNAL TRANSDUCTION;

EID: 43049105018     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2008.01.006     Document Type: Review

References (46)

1. Bao X., Reuss L., and Altenberg G.A. Regulation of purified and reconstituted connexin 43 hemichannels by protein kinase C-mediated phosphorylation of serine 368. J Biol Chem 279 (2004) 20058-20066 (electronic publication 22004 Feb 20017)
2. Boeck C.R., Bronzatto M.J., Souza D.G., et al. The modulation of ecto-nucleotidase activities by glutamate in cultured cerebellar granule cells. Neuroreport 11 (2000) 709-712
3. Bruick R.K. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev 17 (2003) 2614-2623
4. Bruick R.K., and McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294 (2001) 1337-1340
5. Burnstock G. Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clin Med 2 (2002) 45-53
6. Chen Y., Corriden R., Inoue Y., et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314 (2006) 1792-1795
7. Colgan S.P., Eltzschig H.K., Eckle T., et al. Physiologic roles for ecto-5¢-nucleotidase (CD73). Purinergic Signal 2 (2006) 351-360
8. Eckardt D., Theis M., Degen J., et al. Functional role of connexin43 gap junction channels in adult mouse heart assessed by inducible gene deletion. J Mol Cell Cardiol 36 (2004) 101-110
9. Eltzschig H.K., Abdulla P., Hoffman E., et al. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202 (2005) 1493-1505
10. Eltzschig H.K., Eckle T., Mager A., et al. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res 99 (2006) 1100-1108 (electronic publication 2006 Oct 1112)
11. Eltzschig H.K., Ibla J.C., Furuta G.T., et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198 (2003) 783-796
12. Gendron F.P., Benrezzak O., Krugh B.W., et al. Purine signaling and potential new therapeutic approach: possible outcomes of NTPDase inhibition. Curr Drug Targets 3 (2002) 229-245
13. Goodenough D.A., and Paul D.L. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol 4 (2003) 285-294
14. Hasko G., and Cronstein B.N. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25 (2004) 33-39
15. Jaakkola P., Mole D.R., Tian Y.M., et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
16. Kong T., Westerman K.A., Faigle M., et al. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 20 (2006) 2242-2250
17. Lando D., Peet D.J., Whelan D.A., et al. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science 295 (2002) 858-861
18. Ledoux S., Runembert I., Koumanov K., et al. Hypoxia enhances ecto-5¢-nucleotidase activity and cell surface expression in endothelial cells: role of membrane lipids. Circ Res 92 (2003) 848-855
19. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41 (2001) 775-787
20. Linden J. Adenosine in tissue protection and tissue regeneration. Mol Pharmacol 67 (2005) 1385-1387 (electronic publication 2005 Feb 1389)
21. Madara J.L., Parkos C.A., Colgan S.P., et al. Cl- secretion in a model intestinal epithelium induced by a neutrophil-derived secretagogue. J Clin Invest 89 (1992) 1938-1944
22. Madara J.L., Patapoff T.W., Gillece-Castro B., et al. 5′-Adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J Clin Invest 91 (1993) 2320-2325
23. Marcus A.J., Broekman M.J., Drosopoulos J.H., et al. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. J Pharmacol Exp Ther 305 (2003) 9-16
24. McCallion K., Harkin D.W., and Gardiner K.R. Role of adenosine in immunomodulation: review of the literature. Crit Care Med 32 (2004) 273-277
25. Minamino T., Kitakaze M., Morioka T., et al. Cardioprotection due to preconditioning correlates with increased ecto-5′-nucleotidase activity. Am J Physiol 270 (1996) H238-H244
26. Mizumoto N., Kumamoto T., Robson S.C., et al. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 8 (2002) 358-365
27. Mole D.R., Schlemminger I., McNeill L.A., et al. 2-Oxoglutarate analogue inhibitors of HIF prolyl hydroxylase. Bioorg Med Chem Lett 13 (2003) 2677-2680
28. Montesinos M.C., Gadangi P., Longaker M., et al. Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med 186 (1997) 1615-1620
29. Mubagwa K., and Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res 52 (2001) 25-39
30. Napieralski R., Kempkes B., and Gutensohn W. Evidence for coordinated induction and repression of ecto-5′-nucleotidase (CD73) and the A2a adenosine receptor in a human B cell line. Biol Chem 384 (2003) 483-487
31. Nash S., Parkos C.A., Nusrat A., et al. In vitro model of intestinal crypt abscess: a novel neutrophil-derived secretagogue activity. J Clin Invest 87 (1991) 1474-1477
32. Novak I. ATP as a signaling molecule: the exocrine focus. News Physiol Sci 18 (2003) 12-17
33. Nwogu J.I., Geenen D., Bean M., et al. Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction. Circulation 104 (2001) 2216-2221
34. Pellme S., Dahlgren C., and Karlsson A. The two neutrophil plasma membrane markers alkaline phosphatase and HLA class I antigen localize differently in granule-deficient cytoplasts. An ideal plasma membrane marker in human neutrophils is still lacking. J Immunol Methods 325 (2007) 88-95
35. Picher M., Burch L.H., Hirsh A.J., et al. Ecto 5′-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J Biol Chem 278 (2003) 13468-13479 (electronic publication 12003 Jan 13430)
36. Qawi I., and Robson S.C. New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders. Curr Drug Targets 1 (2000) 285-296
37. Schlemminger I., Mole D.R., McNeill L.A., et al. Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases. Bioorg Med Chem Lett 13 (2003) 1451-1454
38. Schofield C.J., and Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5 (2004) 343-354
39. Semenza G.L. HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107 (2001) 1-3
40. Semenza G.L., Agani F., Feldser D., et al. Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv Exp Med Biol 475 (2000) 123-130
41. Shestopalov V.I., and Panchin Y. Pannexins and gap junction protein diversity. Cell Mol Life Sci Nov 5 (2007) 1-19
42. Synnestvedt K., Furuta G.T., Comerford K.M., et al. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 (HIF-1) mediates permeability changes in intestinal epithelia. J Clin Invest 110 (2002) 993-1002
43. Taylor C.T., and Colgan S.P. Hypoxia and gastrointestinal disease. J Mol Med 85 (2007) 1295-1300
44. Thompson L.F., Eltzschig H.K., Ibla J.C., et al. Crucial role for ecto-5¢-nucleotidase (CD73) in vascular leak during hypoxia. J Exp Med 200 (2004) 1395-1405
45. Wang T.F., and Guidotti G. CD39 is an ecto-(Ca2+,Mg2+)-apyrase. J Biol Chem 271 (1996) 9898-9901
46. Zahler S., Hoffmann A., Gloe T., et al. Gap-junctional coupling between neutrophils and endothelial cells: a novel modulator of transendothelial migration. J Leukoc Biol 73 (2003) 118-126